3-nitropropionic acid has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borlongan, CV; Deshpande, SB; Fukuda, A; Inubushi, T; Kumazaki, M; Morikawa, S; Muramatsu, K; Nakajima, K; Nishino, H; Sanberg, PR | 1 |
| Gyun Jung, C; Hayashi, Y; Hida, H; Kodama, Y; Kohri, K; Mogami, M; Nishino, H | 1 |
2 other study(ies) available for 3-nitropropionic acid and tamoxifen
| Article | Year |
|---|---|
Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Antineoplastic Agents, Hormonal; Astrocytes; Blood-Brain Barrier; Calcium; Cell Death; Cerebral Arteries; Corpus Striatum; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Female; Hippocampus; Hypoxia, Brain; Male; Motor Neurons; Neurodegenerative Diseases; Neuroprotective Agents; Nitro Compounds; Orchiectomy; Ovariectomy; Pons; Propionates; Rats; Rats, Wistar; Sex Characteristics; Tamoxifen; Testosterone | 1998 |
Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Bradykinin; Brain; Calcium; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Immunohistochemistry; In Situ Nick-End Labeling; Necrosis; Nitro Compounds; Propionates; Rats; Rats, Wistar; Tamoxifen; von Willebrand Factor | 2002 |